Skip to Main Content

Paper Details

Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
Clin Lymphoma Myeloma Leuk
12
2016
Author NameAffiliation
Robin RuthazerThe Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, MA Tufts Clinical and Translational Sciences Institute, Tufts University
Jessica K PaulusThe Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, MA Tufts Clinical and Translational Sciences Institute, Tufts University
Andrew M EvensTufts University School of Medicine, Tufts Cancer Center, Tufts Medical Center
  • 1 - 3

Datasets